Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches

Notified -

EBC Financial Group Expands Partnership with DiNapoli’s Leading Indicators, Revealing Key Strategies for Navigating Black Swan Events

EBC Financial Group Recognised as “Most Trusted FX Broker” and “Best CFD Broker” at World Finance Awards

GBCI report: Mainland China ranks among the most complex APAC jurisdictions in which to do business. Hong Kong, SAR remains the least complex APAC country to invest in

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

EBC Financial Group Partners with United to Beat Malaria, a Campaign of the United Nations Foundation, to Protect Vulnerable Children and Their Families from Malaria

Carry1st Announces Strategic Investment from Sony Innovation Fund

Boehringer expands production site in Greece for new medicine

Capital Raise of $182 Million Confirms Eavor as the Leader in Scalable Geothermal

Annual Investment Meeting announces new identity as AIM Congress, gears up for 13th edition in Abu Dhabi, May 2024

ATFX Expands its Global Reach with Acquisition of Rakuten Securities Australia